Expression profiling of the intermediate and late stages of poxvirus replication

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 9899-9908

  Yang, Zhilong ^a   Reynolds, Sara E ^a,b   Martens, Craig A ^c   Bruno, Daniel P ^c   Porcella, Stephen F ^c   Moss, Bernard ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b University of Maryland   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HYDROXYUREA; MESSENGER RNA; REPLICATION FACTOR A; REPLICATION INITIATOR PROTEIN DNAA; TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DNA BINDING; DNA PACKAGING; DNA SYNTHESIS; EXPRESSION VECTOR; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SEQUENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POXVIRUS; PRIORITY JOURNAL; PROMOTER REGION; RNA SYNTHESIS; VACCINIA VIRUS; VIRION; VIRUS GENOME; VIRUS REPLICATION; WESTERN BLOTTING;

DNA, COMPLEMENTARY; DNA, VIRAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; POXVIRIDAE; PROMOTER REGIONS, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; VACCINIA VIRUS;

POXVIRIDAE; VACCINIA VIRUS;

EID: 80053956769     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05446-11     Document Type: Article

References (26)

1. Assarsson, E., et al. 2008. Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc. Natl. Acad. Sci. U. S. A. 105:2140-2145.
2. Bailey, T. L., and C. Elkan. 1994. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2:28-36.
3. Baldick, C. J., Jr., and B. Moss. 1993. Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate stage genes. J. Virol. 67:3515-3527.
4. Baldick, C. J., J. G. Keck, and B. Moss. 1992. Mutational analysis of the core, spacer and initiator regions of vaccinia virus intermediate class promoters. J. Virol. 66:4710-4719.
5. Bisht, H., A. S. Weisberg, and B. Moss. 2008. Vaccinia virus L1 protein is required for cell entry and membrane fusion. J. Virol. 82:8687-8694.
6. Bronte, V., et al. 1997. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl. Acad. Sci. U. S. A. 94:3183-3188.
7. Cassetti, M. C., M. Merchlinsky, E. J. Wolffe, A. S. Weisberg, and B. Moss. 1998. DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles. J. Virol. 72:5769-5780.
8. Coupar, B. E. H., M. E. Andre, G. W. Both, and D. B. Boyle. 1986. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur. J. Immunol. 16:1479-1487.
9. Davison, A. J., and B. Moss. 1989. The structure of vaccinia virus early promoters. J. Mol. Biol. 210:749-769.
10. Davison, A. J., and B. Moss. 1989. The structure of vaccinia virus late promoters. J. Mol. Biol. 210:771-784.
11. Earl, P. L., N. Cooper, L. S. Wyatt, B. Moss, and M. W. Carroll. 2001. Preparation of cell cultures and vaccinia virus stocks. Curr. Protoc. Mol. Biol. Chapter 16, unit 16.6. doi: 10.1002/0471142727.mb1616s43.
12. Hänggi, M., W. Bannwarth, and H. G. Stunnenberg. 1986. Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation. EMBO J. 5:1071-1076.
13. Hirschmann, P., J. C. Vos, and H. G. Stunnenberg. 1990. Mutational analysis of a vaccinia virus intermediate promoter in vivo and in vitro. J. Virol. 64:6063-6069.
14. Homann, O. R., and A. D. Johnson. 2010. MochiView: versatile software for genome browsing and DNA motif analysis. BMC Biol. 8:49.
15. Keck, J. G., C. J. Baldick, and B. Moss. 1990. Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late transactivator genes. Cell 61:801-809.
16. Knutson, B. A., M. Drennan, X. Liu, and S. S. Broyles. 2009. Bidirectional transcriptional promoters in the vaccinia virus genome. Virology 385:198-203.
17. Knutson, B. A., X. Liu, J. Oh, and S. S. Broyles. 2006. Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein. J. Virol. 80:6784-6793.
18. Moss, B. 2007. Poxviridae: the viruses and their replication, p. 2905-2946. In D. M. Knipe et al., 5th ed. vol. 2. Lippincott Williams and Wilkins, Philadelphia, PA.
19. Moutaftsi, M., et al. 2010. Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol. 5:221-239.
20. Senkevich, T. G., S. Ojeda, A. Townsley, G. E. Nelson, and B. Moss. 2005. Poxvirus multiprotein entry-fusion complex. Proc. Natl. Acad. Sci. U. S. A. 102:18572-18577.
21. Szajner, P., H. Jaffe, A. S. Weisberg, and B. Moss. 2004. A complex of seven vaccinia virus proteins conserved in all chordopoxviruses is required for the association of membranes and viroplasm to form immature virions. Virology 330:447-459.
22. Vos, J. C., and H. G. Stunnenberg. 1988. Derepression of a novel class of vaccinia virus genes upon DNA replication. EMBO J. 7:3487-3492.
23. Xiang, Y., et al. 1998. The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor. J. Virol. 72:7012-7023.
24. Yang, Z., D. P. Bruno, C. A. Martens, S. F. Porcella, and B. Moss. 2011. Genome-wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts. J. Virol. 85:5897-5909.
25. Yang, Z., D. P. Bruno, C. A. Martens, S. F. Porcella, and B. Moss. 2010. Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proc. Natl. Acad. Sci. U. S. A. 107: 11513-11518.
26. Zhang, Y. F., J. G. Keck, and B. Moss. 1992. Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus. J. Virol. 66:6470-6479.